Paper36069855
Cancer therapeutics based on diverse energy sources.
Son S and 8 others. Chem Soc Rev, 2022. Cited by 93 papers, by iCite.
Cite this record
ConductScience Library. Cancer therapeutics based on diverse energy sources. Papers, record 36069855. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36069855
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| Photochemotherapy | Major topic |
| Humans | |
| Luminescence | |
| Oxygen | |
| Phototherapy |
Source PubMed
Cited by30
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 93 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42412407 | Sequential H2S-Triggered Redox Relay Nanoprobes for Self-Sustained Chem-Illuminating Cascade Photodynamic Therapy. | Angew Chem Int Ed Engl | 2026 | https://conductscience.org/library/papers/42412407 | PubMed |
| 42402086 | Recent advances in metal-organic frameworks for the diagnosis and treatment of breast cancer. | Discov Nano | 2026 | https://conductscience.org/library/papers/42402086 | PubMed |
| 42032703 | Illuminating the path to oncolysis: rise of microbial phototherapy. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/42032703 | PubMed |
| 41853133 | Orchestrating Chemo-Ferroptosis via Nonthermal Magnetocatalysis: A Cascade Amplification Paradigm for Breast Cancer Therapy. | Biomater Res | 2026 | https://conductscience.org/library/papers/41853133 | PubMed |
| 41782834 | An atom-edged magnetic nanomotor for cancer mechanotherapy. | iScience | 2026 | https://conductscience.org/library/papers/41782834 | PubMed |
| 41549220 | Fluorinated Hypoxia-Responsive Aza-BODIPY for NIR-II FL/19F MR/PA Imaging and Phototherapy of Lung Cancer. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41549220 | PubMed |
| 41229889 | Molecular design and excited state dynamics regulation in phototheranostics. | Biophys Rep | 2025 | https://conductscience.org/library/papers/41229889 | PubMed |
| 41215766 | In situ forming hydrogels for colorectal cancer therapy. | Mater Today Bio | 2025 | https://conductscience.org/library/papers/41215766 | PubMed |
| 41063230 | New experimental therapies for glioblastoma: a review of preclinical research. | Acta Neuropathol Commun | 2025 | https://conductscience.org/library/papers/41063230 | PubMed |
| 40873681 | Application of Metal-Organic Frameworks Nanoparticles in the Diagnosis and Treatment of Breast Cancer. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/40873681 | PubMed |
| 40468048 | An endoplasmic reticulum-targeting photodynamic AMPK agonist activates breast cancer immunotherapy through promoting immunogenic cell death and downregulation of PD-L1. | Acta Pharmacol Sin | 2025 | https://conductscience.org/library/papers/40468048 | PubMed |
| 40260131 | Imaging-guided precision hyperthermia with magnetic nanoparticles. | Nat Rev Bioeng | 2025 | https://conductscience.org/library/papers/40260131 | PubMed |
| 40243613 | Fighting Cancer with Photodynamic Therapy and Nanotechnologies: Current Challenges and Future Directions. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40243613 | PubMed |
| 40098106 | Tumor treating fields enhance anti-PD therapy by improving CCL2/8 and CXCL9/CXCL10 expression through inducing immunogenic cell death in NSCLC models. | BMC Cancer | 2025 | https://conductscience.org/library/papers/40098106 | PubMed |
| 40092598 | Near-infrared light-activatable iridium(iii) complexes for synergistic photodynamic and photochemotherapy. | Chem Sci | 2025 | https://conductscience.org/library/papers/40092598 | PubMed |
| 39799105 | Engineered hypoxia-responsive albumin nanoparticles mediating mitophagy regulation for cancer therapy. | Nat Commun | 2025 | https://conductscience.org/library/papers/39799105 | PubMed |
| 39734544 | Formation of reactive species via high power microwave induced DNA damage and promoted intrinsic pathway-mediated apoptosis in lung cancer cells: An in vitro investigation. | Fundam Res | 2024 | https://conductscience.org/library/papers/39734544 | PubMed |
| 39698601 | Analysis of tumor treatment under interventional ultrasound through structural and temporal dynamics: a bibliometric visualization. | Quant Imaging Med Surg | 2024 | https://conductscience.org/library/papers/39698601 | PubMed |
| 39665226 | Implantable Ultrasound-Powered MXene/PVA Hydrogel-Based Generator for Treatment of Glioblastoma. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/39665226 | PubMed |
| 39534680 | An intelligent poly aptamer-encoded DNA nanoclew for tumor site activated mitochondria-targeted photodynamic therapy and MR imaging. | Mater Today Bio | 2024 | https://conductscience.org/library/papers/39534680 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36069855
GET https://conductscience.org/api/papers/v1/36069855/cited_by?page=2